Market Newsdesk

CRESSKILL, N.J. and JERUSALEM, Nov. 17, 2020 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced, non-invasive treatment of brain disorders, today announced that it will host a key opinion leader (KOL) call on Deep Transcranial Magnetic Stimulation (Deep TMS) for treating psychiatric disorders on Monday, November 23, 2020, at 10:00 AM Eastern Time.

The event will feature a presentation by KOL Owen Muir, M.D., a psychiatrist at Brooklyn Minds, who will discuss the current treatment landscape and the unmet medical need in treating patients with psychiatric diseases, such as major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). Dr. Muir will be available to answer questions at the conclusion of the call.

BrainsWay’s management team will also provide an update on the company’s commercial and development efforts around its platform technology, Deep TMS, which achieves deeper and broader brain stimulation. This non-invasive and effective treatment activates deep brain structures by using directed electromagnetic fields that generate excitation or inhibition of neurons in targeted structures of the brain. Deep TMS has received marketing authorization from the U.S. Food and Drug Administration for a variety of patient populations, including in 2013 for patients with MDD, in 2018 for patients with OCD, and in 2020 for patients with smoking addiction.

To register for the call, please click here.

Dr. Muir is co-founder of and Medical Director at Brooklyn Minds. He oversees the site’s cutting-edge Deep Transcranial Magnetic Stimulation (Deep TMS) program. Not only is he one of the five official supervisors in North America for Mentalization-Based Treatment (MBT) for adults, he has additional training in using MBT strategies with adolescents, families, and even teams and systems, and is co-editor of the Springer book “Adolescent Suicide and Self Injury: a Mentalization-Based Treatment Approach.” As Chief Innovation Officer, Dr. Muir has secured Brooklyn Minds’ position as the only site in America offering full, on-model MBT services for adolescents in an outpatient setting. He is proud to have made Brooklyn Minds one of the largest outpatient MBT practices for adults, children, and families in the country. He received his Medical Degree from The University of Rochester School of Medicine, completed adult psychiatry residency at the Hofstra-Northwell School of Medicine at the Zucker Hillside Hospital, and completed his child psychiatry fellowship at NYU School of Medicine.

About OCD

More than 2.5 million adults in the United States suffer from OCD every year. It is a chronic psychiatric illness characterized by a pattern of obsessive thoughts and compulsive repetitive behaviors, which has a significantly destructive effect on patients’ day-to-day activities. Current treatment options include high dosages of SRI antidepressant medications (Clomipramine, Fluoxetine, Sertraline, Paroxetine and Fluvoxamine), a form of CBT called exposure and response prevention (ERP), or a combination of these treatment options. OCD is very difficult to treat since many patients do not respond or tolerate medications and ERP. OCD is usually comorbid with other conditions (such as depression or bipolar disorders), making the patient effectively treatment resistant and increasing the illness and treatment burden. As many as 1 in 2 OCD patients have suicidal thoughts, 1 in 4 will attempt suicide in their lifetime, and the risk of completed suicide is ten times higher with OCD than without.

About BrainsWay

BrainsWay is a commercial stage medical device company focused on the development and sale of non-invasive neurostimulation products using the Company’s proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology. The Company received marketing authorization from the U.S. Food and Drug Administration (FDA) for its products for a variety of patient populations, including in 2013 for patients with major depressive disorder (MDD), in 2018 for patients with obsessive-compulsive disorder (OCD), and in 2020 for patients with smoking addiction. BrainsWay is currently conducting clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders. To learn more, please visit www.brainsway.com

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words.  These forward-looking statements and their implications are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: inadequacy of financial resources to meet future capital requirements; changes in technology and market requirements; delays or obstacles in launching and/or successfully completing planned studies and clinical trials; failure to obtain approvals by regulatory agencies on the Company’s anticipated timeframe, or at all; inability to retain or attract key employees whose knowledge is essential to the development of Deep TMS products; unforeseen difficulties with Deep TMS products and processes, and/or inability to develop necessary enhancements; unexpected costs related to Deep TMS products; failure to obtain and maintain adequate protection of the Company’s intellectual property, including intellectual property licensed to the Company; the potential for product liability; changes in legislation and applicable rules and regulations; unfavorable market perception and acceptance of Deep TMS technology; inadequate or delays in reimbursement from third-party payers, including insurance companies and Medicare; inability to commercialize Deep TMS, including internationally, by the Company or through third-party distributors; product development by competitors; inability to timely develop and introduce new technologies, products and applications, and the effect of the global COVID-19 health pandemic on our business and continued uncertainty and market impact relating thereto.

Any forward-looking statement in this press release speaks only as of the date of this press release. The Company undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws. More detailed information about the risks and uncertainties affecting the Company is contained under the heading “Risk Factors” in the Company’s filings with the U.S. Securities and Exchange Commission.

Contacts:

BrainsWay:
Judy Huber
SVP and Chief Financial Officer
[email protected]

Investors:
Bob Yedid
LifeSci Advisors
646-597-6989
[email protected]

GUELPH, Ontario and LONGUEUIL, Quebec and MONCTON, New Brunswick, Nov. 17, 2020 (GLOBE NEWSWIRE) — TODAY, Atlantic Grain Council, Grain Farmers of Quebec (Producteurs de grains du Québec), and Grain Farmers of Ontario recognize Canadian Minister of Agriculture and Agri-Food Marie-Claude Bibeau for her recent comments highlighting the necessity of AgriStability change and its importance for the upcoming meeting of federal, provincial, territorial (FPT) agriculture ministers.

Atlantic Grains Council, Grain Farmers of Quebec and Grain Farmers of Ontario have made it clear in their recent public awareness campaign that reinstating the former conditions to AgriStability – both raising the trigger to 85 percent and removing the reference margin limits – is essential to offer better support for grain farmers.

AgriStability is a Business Risk Management (BRM) program that only helps farmers during times of great need, and is cost-shared by farmers, the provinces, and the federal government. Minister Bibeau has recognized the need for BRM change.

Minister Bibeau has recently stated that her objective is to find consensus among provinces to “make AgriStability more generous, easier to understand and to proceed with, and also fairer when we look at the different sectors in agriculture.”

She has also stated, “we all already agree on the fact that removing the reference margin limit should be the first step.”

However, the Eastern Canadian grain groups remind Minister Bibeau that raising the trigger for AgriStability to 85 percent must go hand-in-hand with reference margin limit removal.

“We are hopeful when we see Minister Bibeau’s comments that she recognizes the need to increase the trigger and remove the reference margin limit as a solution for AgriStability’s shortfalls, but we are also concerned that without all of the provinces on side, the program won’t be fixed. We cannot afford more disruptions without the proper business assurance programs in place,” said Markus Haerle Chair, Grain Farmers of Ontario.

“For a grain farmer in Eastern Canada, the AgriStability trigger at its current 70 percent equates to no, or very little, support in times of crisis. The FPT meeting represents a unique opportunity for leaders to ensure the health and safety of our food system for generations to come. Minister Bibeau’s support is vital and we urge the provinces to come together to make these much-needed changes to AgriStability,” said Roy Culberson, Chair, Atlantic Grains Council.

“In 2013 AgriStability became a non-viable support program for most grain farmers in Canada and it has remained that way. We need to be prepared for the next market disruption, that requires, at least, this program returning to 85 percent triggers with the reference margin limit removed,” said Christian Overbeek, chair of the Grain Farmers of Quebec.

A November 2020 report by Agri-Food economic Systems (“AgriStability is in Need of Crucial Reform”) stated that bringing the AgriStability trigger back to 85 percent with no reference margin limit “…would provide an improved investment climate for producers, to ensure continuing productivity growth. Increasing the AgriStability trigger does not undermine Canada’s commitments on most distorting agricultural support, nor its commitment to rules-based trade.

The changes from both removal of the reference margin limit and an increase in the trigger to 85 percent are a sufficient starting point. They could offset the growing chorus for ad hoc support, similar to the U.S. programs, by bringing participants back to AgriStability, and giving governments and industry time to set in place a longer term BRM design, consistent with international market disruptions and volatility anticipated. The full report can be read here.

A background document on the state of AgriStability and grain farming can be found here.

Atlantic Grains Council, Producteurs de Grains du Québec/Grain Growers of Quebec, and Grain Farmers of Ontario represent over 40,000 grain and oilseed farmers in Atlantic Canada, Quebec, and Ontario.

MEDIA CONTACTS

Atlantic Grains Council, Heather Russell – 506 381-5404, [email protected]
Producteurs de grains du Québec, Julie Mercier – 514-743-9410, [email protected]
Grain Farmers of Ontario, Victoria Berry, Manager, Communications – 226 820-6641; [email protected]

SAN JOSE, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) — Recognizing the long-lasting impact of the Covid-19 on the workforce, Grokker, the wellbeing engagement solution, recently published “Connection, Humanity & Resilience: Employee Engagement in the New Normal.”

With 70 percent of employees reporting that Covid-19 impacted their daily routine, Grokker created this resource to help organizations navigate pandemic conditions. The guide offers actionable advice employers can use to help their workforce face this new reality, including what they need to take care of themselves, feel well and remain productive.

Grokker’s VP of Business Solutions Dan Graovac commented, “The pandemic shifted the way we experience life — at home and at work. We’ve learned that in order for employees to engage — re-engage or stay engaged — they need to feel a sense of community as well as control over their day-to-day wellbeing. This guide explores the opportunities employers have to play a larger and much-welcomed role in improving employees’ lives, in and out of the workplace.”

In the guide, Grokker makes the business case for prioritizing employee wellbeing and explores the role technology plays in establishing and supporting positive workplace cultures, regardless of employees’ physical location. Grokker also outlines must-haves for employee engagement in today’s world, including how to optimize digital collaboration tools and on-demand wellbeing benefits with connection, humanity and resilience in mind.

Graovac continued, “There’s a new understanding of the relationship between self-care and productivity. It’s about connection, humanity and resilience. Organizations that want to ensure employees feel engaged should step in to support their workforces with resources that empower them and ensure they feel safe and secure.”

“Connection, Humanity & Resilience: Employee Engagement in the New Normal” is available for download here: https://go.grokker.com/employee-engagement-new-normal-ebook.

About Grokker

Grokker is the award-winning wellbeing engagement solution that empowers employees to take control of their wellbeing with personalized programs customized for their interests, abilities and goals and a caring community of experts to encourage them all along the way. Integrating all five dimensions of wellbeing, Grokker connects your global employees in feeling healthy and happy. No matter where they are, Grokker supports your entire workforce so they can maintain physical fitness, eat better, sleep more soundly, address their emotional health and calm financial stress.

Trusted by industry leaders, including Pinterest, Delta Air Lines, Pfizer, eBay, Mandarin Oriental Hotel Group and Dominos, Grokker’s modern, affordable solution builds happier, healthier and more resilient workforces. Learn more at www.grokker.com.

Note to editors: Trademarks and registered trademarks referenced herein remain the property of their respective owners.

Media Contact:
Kate Achille
The Devon Group
(732) 706-0123 ext. 703
[email protected]

PHILADELPHIA, Nov. 17, 2020 (GLOBE NEWSWIRE) — Anexinet Corporation, a leading provider of digital business solutions, today announced its partnership with Alert Logic to deliver its market-defining Managed Detection and Response (MDR) solution to Anexinet customers. Through the agreement, Alert Logic’s cloud-based solution will provide 24/7 security monitoring against hacker threats, malware, and other cyberattacks. When a credible threat is detected, Anexinet’s trained response team will immediately quarantine impacted devices and rebuild systems if necessary.

“The Alert Logic partnership broadens Anexinet’s cybersecurity portfolio with cutting-edge-threat intelligence to protect our customers against increasingly sophisticated and frequent cyberattacks,” said Ryan Benner, VP Infrastructure Services, Anexinet. “Coupled with our deep security expertise, the partnership will bring a turnkey solution for organizations that lack the in-house staff to monitor and administer a security operations center.”

Anexinet’s enhanced solution is an ideal complement for organizations that have some cybersecurity elements in place but need to increase protection without the cost and burden of additional staff, training, or software/hardware upgrades. With this new partnership, customers will receive world-renowned cloud-based threat detection and the proven talent to engage and thwart attacks—without the exorbitant costs of building a solution in-house.

“Through a combination of technology, threat intelligence, and round-the-clock security experts, Alert Logic will help drive new levels of digital asset protection for every Anexinet customer, creating visibility throughout the technology stack, across public clouds, hybrid and on-prem environments,” said Dan Webb, VP of Partner Sales and Alliances at Alert Logic. “We are thrilled to partner with Anexinet to elevate its security offerings and deliver MDR to many more organizations.”

Follow Anexinet on Twitter, LinkedIn, Facebook, or via the Anexinet Insights Blog.

About Anexinet

From intelligent, full-stack engagement strategies and solutions to modern, secure infrastructure products and services, Anexinet focuses on technology-enabled business transformation that drives value. For over two decades, Anexinet has helped companies worldwide solve their most complex challenges—from engaging front-end interactions to dependable back-end solutions. Anexinet’s record of client success springs from a culture rooted in thought leadership and delivery excellence. For more information, please visit www.anexinet.com or follow Anexinet on Twitter or LinkedIn.

For more information, contact:
Betsey Rogers
Public Relations
BridgeView Marketing
603-821-0809
[email protected]

• Assays received for 36 exploration drill holes from satellite targets (Clouds, Twin Hills West and Barking Dog) at Twin Hills.
• These targets are brownfields targets along trend and within a 2500m radius from Twin Hills Central.
• Significant new gold discoveries made at Clouds West and East, respectively 500m and 1500m east along strike from Twin Hills Central. Gold mineralization intersected includes:
  • 27m @ 1.22g/t (OKD059: 143 – 170), incl. 16m @ 1.74g/t (Clouds West)
  • 76m @ 0.75g/t (OKD093: 66 – 142m) incl. 37m @ 0.97g/t (Clouds East)
  • 22m @ 1.19g/t (OKD096: 120 – 142m) incl. 9m @ 2.44g/t (Clouds East)
• Both Clouds East and West lie along a prominent, high-intensity IP anomaly along strike from Twin Hills Central, therefore potentially doubling the Twin Hills Central mineralized strike length from 1500 to over 3000m in length.
• Rapid step-out drill program ongoing to define & delineate the resource potential at Clouds East and West, as well as the gaps in between, and Twin Hills Central.
• Additional significant drill intercepts at Twin Hills West and Barking Dog further reinforce the brownfields exploration potential of the overall Twin Hills gold system.

VANCOUVER, British Columbia, Nov. 17, 2020 (GLOBE NEWSWIRE) — Osino Resources Corp. (TSXV: OSI) (FSE: RSR1) (OTCQB: OSIIF) (“Osino” or “the Company”), is pleased to provide an update on the brownfields exploration drilling at the Clouds, Twin Hills West and Barking Dog targets adjacent to and along trend from Osino’s Twin Hills Central (“THC”) gold project in north-central Namibia, where the Company holds a dominant 7,000 km² land position. THC is part of the large, sedimentary-hosted and structurally controlled Twin Hills gold system which was discovered by Osino in 2019.

Significant assays received at Clouds West and East confirm the discovery of two new zones of gold mineralization, including higher grade shoots up to 1500m from the eastern edge of THC. The Clouds mineralization occurs along a strong IP anomaly, which appears continuous along the entire combined 3100m strike length (Figure 2 below indicates details of the Clouds drilling and coincident IP anomaly).

These new discoveries indicate the potential to double the mineralized strike at THC, thereby also significantly growing THC’s contiguous resource potential. A high intensity drill program has been put in place to drill out the Clouds targets and the gap between THC and Clouds before the end of Q1 2021.

David Underwood, Osino’s Vice President Exploration commented: “The mineralization drilled at Clouds West and East is a very exciting step forward and provides the first indication that economic mineralization at Twin Hills Central may double in an eastward direction to over 3000m in strike length. These new discoveries provide a glimpse of the substantial growth potential of the overall Twin Hills Central gold deposit and nearby satellite bodies along strike and on parallel trends. We have now dedicated several drill rigs to theentire Clouds target as well as the gap between THC and Clouds West.At the same time, resource drilling at Twin Hills Central is continuing on schedule with rigs concentrating on the northern and eastern extensions as well as the remaining in-fill holes. The positive results at Twin Hills West and Barking Dog are the best holes in these areas to date and will direct further exploration early next year.”

In addition, narrow but significant intercepts have been returned from both Twin Hills West (16m @ 1.38g/t) and Barking Dog (8m @ 1.30g/t) which provide a clear indication of where future drilling should be focused at these targets. The intercept on the south side of Barking Dog is the first positive result in this part of the Twin Hills system and indicates that the mineralization is developing towards the southeast – see Figure 1.

Figure 1 is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/41ccf1e7-731e-407d-bb36-aa427738d67d

To date a total of 36 holes have been drilled at Clouds, Twin Hills West (“THW”) and Barking Dog (See Figure 1 for location of targets and Table 1 for list of drill holes and significant assays) with significant assay results having been received.

Detail
ed Results of Exploration Drilling

Clouds

The Clouds target is a 1200m long gold-in-calcrete, magnetic and IP anomaly that lies 500m on strike to the east of THC. Two holes were drilled on the west side of Clouds in 2019 with a best intercept of 7m @ 0.71g/t in hole OKD025. An additional seven holes were drilled at Clouds West in the current program with a best result of 27m @ 1.22g/t (inc. 16m @ 1.74g/t) in hole OKD059, 180m to the west of OKD025 – see Figure 2. The gold mineralization is steeply dipping to the north and occurs within sheared and altered turbidites, hosting centimeter-scale veinlets of arsenopyrite and pyrrhotite. This mineralization is similar in style to THC.

Two holes were also drilled at Clouds East in 2019 with a best result of 27m @ 0.80g/t (inc. 6m @ 1.25g/t) in OKD057. In the current program three additional step-out holes were drilled at Clouds East with all of the holes intersecting significant mineralization with a best of 76m @ 0.75g/t (inc. 37m @ 0.97g/t) and 19m @ 1.19g/t (inc. 8m @ 1.67g/t) – see Figure 2.

The intercepts at Clouds to date look narrower than at THC but the widest part of the IP anomaly in the center of the Clouds target has yet to be drilled. If the mineralization is continuous from THC to Clouds East, the total strike length of mineralization could potentially be increased to 3100m.

Figure 2 is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/8e892c0d-209e-4be8-9ac2-687fc2461428 

Twin Hills West

In the 2020 exploration program, four holes were drilled to the south and west of OKD011 (21m @ 0.83g/t) and OKD019 (11m @ 1.08g/t) to follow-up on the results from 2019. The best result from the recent drilling is 16m @ 1.38g/t in the southernmost hole (OKD037) – see Figure 1. This hole appears to have intersected the top of a developing ore shoot and step-out drilling is being planned for early 2021 to follow-up on OKD037 and also to test the strong IP and gold-in-calcrete anomaly at THW to the north of the current drilling.

Eight holes were drilled at THW in 2019 with the initial holes (OKD011 and OKD013) orientated on an azimuth of 160^o as at THC. However, the drill was turned around to 340^o after 50m of the second hole as it became clear that the geology at THW dips steeply to the south, in contrast to the rest of Twin Hills where it dips to the north.

Barking
Dog

In 2019 six holes were drilled at Barking Dog across magnetic and geochemical anomalies with no significant gold intercepts. A further four holes were drilled during the 2020 program over a prominent IP anomaly to the south of Barking Dog. Hole OKD063 on the east side of the anomaly returned a positive intercept of 8m @ 1.30g/t. This mineralization will be followed-up along strike and down-dip to see if it develops into a wider shoot towards the east – see Figure 1.

These drill results have provided validation of the quality of Osino’s new IP targets and provide impetus to further accelerating Osino’s brownfields exploration program in addition to the ongoing resource drilling.

Table 1: Summary of Drill
Intercepts from
2020 Exploration Drilling at
Twin Hills
Project.

Hole	From	To		Width			Grade	X	Y
Clouds West
OKD059 1	143	170		27			1.22	601658	7584988
inc .				16			1.74
OKD062	157	167		10			0.90	601623	7585083
OKD065	No significant intercepts							601851	7584960
OKD082	No significant intercepts							601676	7584941
OKD086	No significant intercepts							601703	7585008
OKD090	95	107		12			0.63	601629	7584920
Clouds East
OKD054	No significant intercepts							602632	7585268
OKD0571				27			0.80	602598	7585361
inc.				6			1.25
OKD093 1	66	142		76			0.75	602585	7585408
OKD096 1	55	142		87			0.62	602630	7585428
OKD098	65	76		11			0.61	602537	7585395
and	81	100		19			0.96
Twin Hills West
OKD037 1	169	185		16			1.38	597086	7583032
and	269	278		9			0.52
OKD040	45	50		5			1.30	596962	7583081
OKD043	55	59		4			1.96	596928	7583175
OKD045	No significant intercepts							596894	7583268
Barking Dog
OKD051	No significant intercepts							604199	7585658
OKD060	No significant intercepts							604165	7585752
OKD061	No significant intercepts							604551	7585860
OKD063	61		69		8	1.30		604586	7585766

¹

Unconstrained intersections

Notes: All reported intercepts are apparent widths rounded to the nearest meter. True widths are unknown at this stage. Included intercepts are at 0.4g/t cut-off, minimum 2m wide and no more that 2m internal dilution.
All holes in table above
drilled on azimuth 160 degrees.
Collar positions are in UTM WGS84, surveyed accurately
with DGPS
.

Q
ualified Person

David Underwood, BSc. (Hons) is Vice President Exploration of Osino Resources Corp. and has reviewed and approved the scientific and technical information in this news release and is a registered Professional Natural Scientist with the South African Council for Natural Scientific Professions (Pr. Sci. Nat. No.400323/11) and a Qualified Person for the purposes of National Instrument 43-101.

Quality Assurance

All Osino sample assay results have been independently monitored through a quality assurance / quality control (“QA/QC”) program including the insertion of blind standards, blanks and duplicate samples. QA/QC samples make up 10% of all samples submitted. Logging and sampling is completed at Osino’s secure facility located in Omaruru near the Twin Hills Project. Drill core is sawn in half on site and half drill-core samples are securely transported to the Actlabs sample prep facility in Windhoek, Namibia. The core is dried, crushed to 90% -10mesh, split to 350g and pulverised to 90% -140mesh. Sample pulps are sent to Actlabs in Ontario, Canada for analysis. Gold analysis is by 30g fire assay with AA finish and automatically re-analysed with Gravimetric finish if Au >5g/t. In addition, pulps undergo 4-Acid digestion and multi-element analysis by ICPAES or ICP-MS. RC drill samples are prepared at Actlabs sample prep facility in Windhoek, Namibia. The RC chips are dried, crushed to 90% -10mesh, split to 350g and pulverised to 90% -140mesh. Sample pulps are sent to Actlabs in Ontario, Canada for analysis. Gold analysis is by 30g fire assay with AA finish and automatically re-analysed with Gravimetric finish if Au >5g/t.

About Osino
Resources

Osino is a Canadian gold exploration company, focused on the acquisition and development of gold projects in Namibia. Having achieved our initial vision of finding Namibia’s next significant gold deposit, we are now focused on rapidly advancing the exciting Twin Hills gold discovery and to make new discoveries elsewhere along the belt. This we will achieve with Osino’s winning formula of combining innovation & drive with technical experience & strong financial backing.

Our portfolio of exclusive exploration licenses is located within Namibia’s prospective Damara mineral belt, mostly in proximity to and along strike of the producing Navachab and Otjikoto Gold Mines. Osino is targeting gold mineralization that fits the broad orogenic gold model. We are actively advancing a range of gold discoveries, prospects and targets across our approximately 7,000km² ground position by utilizing a portfolio approach geared towards discovery.

Osino’s focus in 2020 is on further advancing the Twin Hills and Goldkuppe discoveries within the developing Karibib Gold District, testing our Otjikoto East and Otjiwarongo targets and generating new ones on our remaining licenses. Our core projects are favorably located north and north-west of Namibia’s capital city Windhoek. By virtue of their location, the projects benefit significantly from Namibia’s well-established infrastructure with paved highways, railway, power and water in close proximity. Namibia is mining-friendly and lauded as one of the continent’s most politically and socially stable jurisdictions. Osino continues to evaluate new ground with a view to expanding its Namibian portfolio.

Further details are available on the Company’s website at https://osinoresources.com/

CONTACT INFORMATION

Osino Resources Corp.
Heye Daun: CEO
Tel: +27 (21) 418 2525
[email protected]

Julia Becker: Investor Relations Manager
Tel: +1 (604) 785 0850
[email protected]

Cautionary Statement Regarding Forward-Looking Information

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, without limitation, statements regarding the use of proceeds from the Company’s recently completed financings, and the
future plans
or prospects of the Company. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”.
 
Forward-looking statements are necessarily based upon a number of assumptions that, while considered reasonable by management, are inherently subject to business, market and economic risks, uncertainties and contingencies that may cause actual results, performance or achievements to be materially different from those expressed or implied by forward-looking statements.
 
Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information.
 
Other factors which could materially affect such forward-looking information are described in the risk factors in the Company’s most recent annual management’s discussion and analysis which is available on the Company’s profile on SEDAR at
 
www.sedar.com
. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

ROCKVILLE, Md., Nov. 17, 2020 (GLOBE NEWSWIRE) — Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases, today announced a collaboration with The Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC) led by Eva Morava-Kozicz, M.D. Ph.D., Principal Investigator of the trial, Professor of Medical Genetics, Senior Associate Consultant, Department of Clinical Genomics, Mayo Clinic and Editor in Chief of the Journal of Inherited Metabolic Disease on a prospective pivotal trial evaluating the safety and efficacy of CERC-801 in patients suffering from Phosphoglucomutase-1 deficiency related congenital disorders of glycosylation (PGM1-CDG).

Dr. H. Jeffrey Wilkins, M.D., Chief Medical Officer for Cerecor, stated, “We are delighted to be working with the premier group of thought leaders from The FCDGCto study CERC-801 in patients suffering from PGM1-CDG. We intend to use the data generated from this prospective trial to supportour submission package to the FDA for CERC-801 as the first approved product for the treatment and management of PGM1-CDG.”

This trial will study the safety, tolerability, and efficacy of CERC-801 in patients with PGM1-CDG using daily therapeutic doses of CERC-801 in approximately ten patients. Outcome measures will include evaluation of clinical symptoms and clinically meaningful biomarkers.

Andrea Miller, JD, MHA, President & Founder of CDG CARE, stated, “We are truly excited to see the collaboration between FCDGC and Cerecor and this prospective trial in PGM1-CDG. CDG is an area of high unmet need where there are no approved therapies today. The possibility for thereto be an approved therapy for PGM1-CDG is exciting and has the potential to improve the quality of life of patients suffering fromthis ultra rare form of CDG.”

About PGM1-CDG

CDGs are a group of rare, inherited, metabolic disorders caused by glycosylation defects that present as a broad range of clinical symptoms, including coagulopathy, hepatopathy, myopathy, hypoglycemia, protein-losing enteropathy and reduced cell counts. CDG patients are born with a genetic defect that hinders their ability to utilize certain monosaccharides in the production of glycoproteins. A deletion or misplacement of a sugar subunit produces a dysfunctional glycoprotein, resulting in a myriad of medical issues.

While there are no U.S. Food and Drug Administration-approved treatments for the treatment of CDGs, dietary monosaccharide formulations have been shown to alleviate several of the clinical manifestations in CDG patients. These restorative monosaccharide therapies work by increasing the availability of metabolic intermediates for glycoprotein synthesis. PGM1-CDG is caused by mutation in the PGM1 gene encoding an enzyme responsible for the interconversion of glucose-6-phosphate to glucose-1-phosphate. Glucose-1-phosphate can be utilized to supply UDP-galactose, a substrate that donates galactose subunits for glycoprotein synthesis. CERC-801 uses therapeutic doses of D-galactose to restore glycosylation in patients with PGM1 deficiency.

About FCDGC

The Frontiers in CDG Consortium leverages cross-disciplinary, team-based clinical science to address decades of unresolved questions, increase clinical trial readiness, advance and share knowledge, develop treatments, and address current unmet patient needs. The Consortium establishes a nation-wide network of ten regional academic centers, the Sanford Burnham Presbyterian Medical Discovery Institute and the patient advocacy group CDG CARE.

CDG CARE (Community Alliance and Resource Exchange) is the Patient Advocacy Group representing all Congenital Disorders of Glycosylation (CDG) and Deglycosylation (CDDG) for the FCDGC. CDG CARE is a nonprofit 501(c)(3) organization founded by parents seeking information and support for a group of disorders known as CDG. Their mission is to promote greater awareness and understanding of CDG, to provide information and support to families affected by CDG, and to advocate for and fund scientific research to advance the diagnosis and treatment of all CDGs.

About CERC-800s

CERC-801, CERC-802 and CERC-803 are restorative monosaccharide therapies with known therapeutic utility for the treatment of select CDGs. Oral administration at therapeutic doses of CERC-801, CERC-802, and CERC-803 replenishes critical metabolic intermediates that are reduced or absent due to genetic mutation, overcoming single enzyme defects in respective CDGs to support glycoprotein synthesis, maintenance and function.

About Cerecor

Cerecor is a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases.  The company is advancing its clinical-stage pipeline of innovative therapies that address unmet patient needs within rare and orphan diseases.  The company’s rare disease pipeline includes CERC-801, CERC-802 and CERC-803 (“CERC-800 compounds”), which are therapies for inherited metabolic disorders known as congenital disorders of glycosylation.  The U.S. Food and Drug Administration (“FDA”) granted Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) to all three CERC-800 compounds, thus potentially qualifying the Company to receive a Priority Review Voucher (PRV) upon approval of each new drug application (NDA).  The company is also developing CERC-002, CERC-006 and CERC-007.  CERC-002 is an anti-LIGHT monoclonal antibody being developed for the treatment of severe pediatric-onset Crohn’s disease, and is also being studied for COVID-19 acute respiratory distress syndrome.  CERC-006 is a dual mTOR inhibitor being developed for the treatment of complex lymphatic malformations and has been granted ODD and RPDD by the FDA, thus potentially qualifying the company to receive a fourth PRV upon approval of an NDA.  CERC-007 is an anti-IL-18 monoclonal antibody being developed for the treatment of autoimmune inflammatory diseases such as Still’s disease and multiple myeloma. 

For more information about Cerecor, please visit www.cerecor.com.

Forward-Looking Statements

This press release may include forward-looking statements made pursuant to the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to significant risks and uncertainties that are subject to change based on various factors (many of which are beyond Cerecor’s control), which could cause actual results to differ from the forward-looking statements. Such statements may include, without limitation, statements with respect to Cerecor’s plans, objectives, projections, expectations and intentions and other statements identified by words such as “projects,” “may,” “might,” “will,” “could,” “would,” “should,” “continue,” “seeks,” “aims,” “predicts,” “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “potential,” or similar expressions (including their use in the negative), or by discussions of future matters such as: the development of product candidates or products; timing and success of trial results and regulatory review; potential attributes and benefits of product candidates; and other statements that are not historical. These statements are based upon the current beliefs and expectations of Cerecor’s management but are subject to significant risks and uncertainties, including: drug development costs, timing and other risks, including reliance on investigators and enrollment of patients in clinical trials, which might be slowed by the COVID-19 pandemic; regulatory risks; Cerecor’s cash position and the potential need for it to raise additional capital; general economic and market risks and uncertainties, including those caused by the COVID-19 pandemic; and those other risks detailed in Cerecor’s filings with the Securities and Exchange Commission. Actual results may differ from those set forth in the forward-looking statements. Except as required by applicable law, Cerecor expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Cerecor’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

For media and investor inquiries

James Harrell
Investor Relations
Chief Commercial Officer
Cerecor Inc.
[email protected]
623.439.2220 office

SAN MATEO, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) — Farsight Security®, Inc., the leader in DNS Intelligence, today announced that Farsight DNSDB®, the world’s largest historical DNS intelligence database, is now integrated with Palo Alto Networks Cortex XSOAR, the industry’s first extended security orchestration, automation and response platform that empowers security teams by simplifying and harmonizing security operations across their enterprise. Through this integration, Farsight DNSDB and Cortex XSOAR enable security analysts to uncover and gain context for all connected DNS-related digital artifacts, from domain names and IP addresses to nameservers and MX records, in seconds.

Farsight Security is offering a free content pack entitled “DNSDB” in the Cortex XSOAR integrations marketplace. The DNSDB content pack contains three playbooks that integrate into existing automation processes to automatically contextualize and correlate all DNS-related assets. For example, while responding to a reported malicious domain, users can uncover the associated domains and IP addresses to reveal the attacker’s infrastructure which may have already been used or may be used in the future for an attack.

Using the playbooks, security practitioners can retrieve:

• All hostnames seen for a given IP around the time of observation.
• All IPs seen for a given hostname around the time of observation.
• A limited number of other hostnames seen on the same IPs as the target hostname.

“A broad and open ecosystem is vital to the successful adoption of any XSOAR platform,” said Rishi Bhargava, vice president of product strategy, Cortex XSOAR at Palo Alto Networks. “We are proud to welcome Farsight Security to the Cortex XSOAR ecosystem, which has partner-owned integrations that enable customers to streamline security processes, connect disparate security tools and technologies, and maintain the right balance of machine-powered security automation and human intervention.”

“Every online transaction, good or bad, begins with a DNS lookup. Yet domain names and IP addresses can be used and discarded by criminals in minutes or even seconds. Farsight DNSDB enables users to map malicious infrastructure – even when the website has disappeared or the IP address or nameserver for the suspicious DNS asset has changed. Farsight Security is proud to be part of the Cortex XSOAR marketplace and these playbooks will measurably improve the speed and accuracy of our joint customer investigations,” said Farsight Security CEO Dr. Paul Vixie.

Cortex XSOAR is an extended security orchestration, automation and response platform that unifies case management, automation, real-time collaboration and threat intel management to transform every stage of the incident lifecycle. Teams can manage alerts across all sources, standardize processes with playbooks, take action on threat intel and automate response for any security use case — resulting in significantly faster responses that require less manual review.

About
Farsight
Security, Inc.

Farsight Security, Inc. is the world’s largest provider of historical and real-time passive DNS data. We enable security teams to qualify, enrich and correlate all sources of threat data and ultimately save time when it is most critical – during an attack or investigation. Our solutions provide enterprise, government and security industry personnel and platforms with unmatched global visibility, context and response. Farsight Security is headquartered in San Mateo, California, USA. Learn more about how we can empower your threat platform and security team with Farsight Security passive DNS solutions at https://www.farsightsecurity.com/ or follow us on Twitter: @FarsightSecInc.

Contact

Karen Burke
Director of Corporate Communications
Farsight Security, Inc.
[email protected]

VANCOUVER, British Columbia, Nov. 17, 2020 (GLOBE NEWSWIRE) — Corvus Gold Inc. (“Corvus” or the “Company”) – (TSX: KOR, NASDAQ: KOR) announces it has received additional results from its new Lynnda Strip discovery east and west of the previously announced discovery hole ML20-168 (NR20-17: 106.7m @ 0.71g/t gold & 48.8m @ 0.90 g/t gold). The new oxide, vein intersections are within broad zones of lower-grade disseminated mineralization highlighted by an Upper Zone vein in hole ML20-170 (42.7m @ 2.06 g/t gold including 12.2m @ 4.88 g/t gold) and a Lower Zone vein in hole ML20-166 (33.5m @ 1.63 g/t gold including 7.6m @ 3.96 g/t gold). These thick zones of mineralization continue to display a gold system thickness of 150-200 metres that all end in mineralization indicating additional potential at depth (Figure 1 & Table 1).

The higher-grade vein systems at Lynnda Strip are associated with gray quartz stockwork systems that best develop along moderately west dipping north-south structural zones and reactively flat, east dipping stratigraphic contact related zones (Figure 2). These veins appear related to subsidiary, structural zones in the hanging wall of large displacement, north-south trending major faults and are surrounded by broad zones of disseminated lower-grade oxide gold mineralization. Corvus believes that ongoing core drilling at Lynnda Strip has shown the system could extend an addition 100 metres below the initial RC drill holes announced to date with oxidation that could be excess of 500 metres deep.  

The dimensions of the Lynnda Strip system is in excess of 500 metres East-West and is displaying a system thickness that could be in excess of 200 metres.  As like other systems in the Bullfrog District that are related to North-South trending structural zones, the potential strike extent could be multiples of the currently known width.   Corvus believes that this system could be very large and currently appears to be a higher-grade heap-leach open pit deposit. Corvus’ strategic land position will allow it to assess the width of this north-south trending system which initially will target an approximate 1 km-long fence assessing three major structural zones: Lynnda Strip, South Merlin and Owl Creek which is the north extension of Mother Lode zone (Figure 3 & 4).

Jeffrey Pontius, President and CEO of Corvus, said, “These new results from Lynnda Strip along with the deep extension of the gold system that we see in the on-going core drilling program is outlining a large new discovery of a deeply oxidized heap leach deposit. Corvus’ continued assessment and definition of its size and quality will be a major interest driver for the District. The Lynnda Strip target is blind, under non-mineralized cover, resembling all major discoveries made in the District to date and reinforces the exploration potential of this area. When looked at in the context of other western Nevada major, volcanic related gold systems like Round Mountain and Comstock, we could be just scratching the surface of the potential of this re-emerging Nevada Gold District.”

Table 1:


Lynnda Strip –


Mineral Resource Expansion Phase-4


Results


(Reported intercepts are not true widths as there is currently insufficient data to calculate true orientation in space. Mineralized intervals are calculated using a 0.
1
g/t cut-off unless otherwise indicated below)

Drill Hole #	from (m)	to (m)	Interval (m)	Gold (g/t)	Silver (g/t)	Comment
ML 20 – 166 AZ 085 dip-70	167.64	175.26	7.62	0.46	n/a	Upper Zone
	211.84	272.80	60.96	0.50	n/a
inc	222.50	225.55	3.05	1.10	n/a	Upper Vein #1 1 g/t cut
	281.94	338.33	56.39	0.93	n/a
inc	292.61	313.94	21.33	1.26	n/a	Upper Vein #2 1 g/t cut
	356.62	390.14	33.52	1.63	n/a	Lower Zone
inc	359.66	371.86	12.20	2.98	n/a	Lower Vein #1 1 g/t cut
inc	361.19	368.81	7.62	3.96	n/a	2g/t cut
	394.72	402.34	7.62	1.70	n/a	Lower Vein #2 Hole ended in vein

ML 20 – 170 AZ 085 dip-70	249.94	292.61	42.67	2.06	n/a	Upper Zone Vein #1
inc	251.46	278.89	27.43	3.08	n/a	1 g/t cut
inc	263.65	275.84	12.19	4.88	n/a	2 g/t cut
	313.94	333.76	19.82	0.16	n/a
	338.33	353.57	15.24	0.24	n/a
	368.81	376.43	7.62	0.18	n/a
	399.29	448.06	48.77	0.39	n/a	Lower Zone
	460.25	466.34	6.09	0.78	n/a
	472.44	499.87	27.43	0.24	n/a	Mid-Lower Zone Hole e nded in gold

CH20 – 15 AZ 295 dip-62	376.43	428.24	51.81	0.70	n/a	Ending in Mineralization
inc	388.62	393.19	4.57	1.37	n/a	Upper Vein #1
inc	408.43	419.10	10.67	1.14	n/a	Upper Vein #2

Figure 1


.


L


ocation


map for new Lynnda Strip drill holes, Mother Lode Project


,


East Bullfrog Mining District,


Nevada
 
https://www.globenewswire.com/NewsRoom/AttachmentNg/7b3f7573-6959-464f-85f5-eca2b0bcb6e4

Figure 2. Lynnda Strip cross-section


https://www.globenewswire.com/NewsRoom/AttachmentNg/74055820-790c-42ba-b3d7-d9bbe27755e7

Figure


3


. Lynnda Strip vein/stockwork zones: Upper Vein in hole ML20-169CT


https://www.globenewswire.com/NewsRoom/AttachmentNg/394079e0-e5f9-4229-afe0-bfb9265856c5

Figure


4


.


Lynnda Strip


vein


/stockwork zones


, Lower Vein in hole ML20-167


CT


(red circle is visible gold)


assays pending


https://www.globenewswire.com/NewsRoom/AttachmentNg/e90c85cb-e04e-4733-a775-514166e8762e  

Qualified Person and Quality Control/Quality Assurance

Jeffrey A. Pontius (CPG 11044), a qualified person as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI 43-101”), has supervised the preparation of the scientific and technical information that forms the basis for this news release and has reviewed and approved the disclosure herein. Mr. Pontius is not independent of Corvus, as he is the CEO & President and holds common shares and incentive stock options.

Carl E. Brechtel, (Nevada PE 008744 and Registered Member 353000 of SME), a qualified person as defined by NI 43-101, has coordinated execution of the work outlined in this news release and has also reviewed and approved the disclosure herein. Mr. Brechtel is not independent of Corvus, as he is the COO and holds common shares and incentive stock options.

The work program at Mother Lode and North Bullfrog was designed and supervised by Mark Reischman, Corvus Gold’s Nevada Exploration Manager, who is responsible for all aspects of the work, including the quality control/quality assurance program. On-site personnel at the project log and track all samples prior to sealing and shipping. Quality control is monitored by the insertion of blind certified standard reference materials and blanks into each sample shipment. All mineral resource sample shipments are sealed and shipped to American Assay Laboratories (“AAL”) in Reno, Nevada, for preparation and assaying. AAL is independent of the Company. AAL’s quality system complies with the requirements for the International Standards ISO 9001:2000 and ISO 17025:1999. Analytical accuracy and precision are monitored by the analysis of reagent blanks, reference material and replicate samples. Finally, representative blind duplicate samples are forwarded to AAL and an ISO compliant third-party laboratory for additional quality control. Mr. Pontius, a qualified person, has verified the data underlying the information disclosed herein, including sampling, analytical and test data underlying the information by reviewing the reports of AAL, methodologies, results and all procedures undertaken for quality assurance and quality control in a manner consistent with industry practice, and all matters were consistent and accurate according to his professional judgement. There were no limitations on the verification process.

Metallurgical testing on North Bullfrog and Mother Lode samples has been performed by McClelland Analytical Services Laboratories Inc. of Sparks Nevada (“McClelland”), Resource Development Inc. of Wheatridge, CO (RDi) and Hazen Research Inc. of Golden, CO (HRi). McClelland is an ISO 17025 accredited facility that supplies quantitative chemical analysis in support of metallurgical, exploration and environmental testing using classic methods and modern analytical instrumentation. McClelland has met the requirements of the IAS Accreditations Criteria for Testing Laboratories (AC89), has demonstrated compliance with ANS/ISO/IEC Standard 17025:2005, General requirements for the competence of testing and calibration laboratories, and has been accredited, since November 12, 2012. Hazen Research Inc. (“Hazen”), an independent laboratory, has performed flotation, AAO testing and cyanide leach testing on samples of sulphide mineralization from the YellowJacket zone and Swale area of Sierra Blanca, and roasting tests on Mother Lode flotation concentrate. Hazen holds analytical certificates from state regulatory agencies and the US Environmental Protection Agency (the “EPA”). Hazen participates in performance evaluation studies to demonstrate competence and maintains a large stock of standard reference materials from the National Institute of Standards and Technology (NIST), the Canadian Centre for Mineral and Energy Technology (CANMET), the EPA and other sources. Hazen’s QA program has been developed for conformance to the applicable requirements and standards referenced in 10 CFR 830.120 subpart A quality assurance requirements, January 1, 2002. Resource Development Inc. is a state-of-the-art laboratory for metallic and industrial minerals filling a need for high quality, cost-effective, and timely technical services for the international mining industry.

About the North Bullfrog


& Mother Lode


Projects, Nevada

Corvus controls 100% of its North Bullfrog Project, which covers approximately 90.5 km² in southern Nevada.  The property package is made up of a number of private mineral leases of patented federal mining claims and 1,134 federal unpatented mining claims.  The project has excellent infrastructure, being adjacent to a major highway and power corridor as well as a large water right. The Company also controls 445 federal unpatented mining claims on the Mother Lode project which totals approximately 36.5 km² which it owns 100%.  The total Corvus 100% land ownership now covers over 127 km², hosting two major new Nevada gold discoveries.

About Corvus Gold Inc.

Corvus Gold Inc. is a North American gold exploration and development company, focused on its near-term gold-silver mining project at the North Bullfrog and Mother Lode Districts in Nevada. In addition, the Company controls a number of royalties on other North American exploration properties representing a spectrum of gold, silver and copper projects. Corvus is committed to building shareholder value through new discoveries and the expansion of its projects to maximize share price leverage in an advancing gold and silver market.

On behalf of
Corvus Gold Inc.

(signed) Jeffrey A. Pontius
Jeffrey A. Pontius,
President & Chief Executive Officer

Contact Information:		Ryan Ko
		Investor Relations
		Email: [email protected]
		Phone: 1-844-638-3246 (toll free) or (604) 638-3246

Cautionary Note Regarding Forward-Looking Statements

This news release contains forward-looking statements and forward-looking information (collectively, “forward-looking statements”) within the meaning of applicable Canadian and US securities legislation. All statements, other than statements of historical fact, included herein including, without limitation, statements regarding the possible events, conditions or financial performance that is based on assumptions about future economic conditions and courses of action; potential expansion of the deposit; the rapid and effective capture of the potential of our
Mother Lode
project; the potential for new deposits and expected increases in the system’s potential; anticipated content, commencement and cost of exploration programs; anticipated exploration program results and expansion of existing programs; the discovery and delineation of mineral deposits/resources/reserves; the potential to discover additional high grade veins or additional deposits; the growth potential of the Mother Lode project
s
; and the potential for any mining or production at the Mother Lode
& North Bullfrog
project
s
, are forward-looking statements. Information
concerning mineral resource estimates may be deemed to be forward-looking statements in that it reflects a prediction of the mineralization that would be encountered if a mineral deposit were developed and mined. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove to be correct. Forward-looking statements are typically identified by words such as: believe, expect, anticipate, intend, estimate, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking statements as a result of various factors, including, but not limited to, variations in the nature, quality and quantity of any mineral deposits that may be located,
variations in the market price of any mineral products the Company may produce or plan to produce, the Company’s inability to obtain any necessary permits, consents or authorizations required for its activities, the Company’s inability to produce minerals from its properties successfully or profitably, to continue its projected growth, to raise the necessary capital or to be fully able to implement its business
strategies, and other risks and uncertainties disclosed in the Company’s 2020 Annual Information Form and latest interim Management Discussion and Analysis filed with certain securities commissions in Canada and the Company’s most recent filings with the United States Securities and Exchange Commission (the “SEC”). The Company
does not undertake to update any forward-looking
statements
, except in accordance with applicable securities laws.
All of the Company’s Canadian public disclosure filings in Canada may be accessed via

www.sedar.com

and filings with the SEC may be accessed via

www.sec.gov

and readers are urged to review these materials, including the technical reports filed with respect to the Company’s mineral properties.

Cautionary Note to US Investors

NI 43-101 is a rule developed by the Canadian Securities Administrators which establishes standards for all public disclosure an issuer makes of scientific and technical information concerning mineral projects. Unless otherwise indicated, all resource estimates contained in or incorporated by reference in this press release have been prepared in accordance with NI 43-101 and the guidelines set out in the Canadian Institute of Mining, Metallurgy and Petroleum (the “CIM”) Standards on Mineral Resource and Mineral Reserves, adopted by the CIM Council on November 14, 2004 (the “CIM Standards”) as they may be amended from time to time by the CIM.

United States investors are cautioned that the requirements and terminology of NI 43-101 and the CIM Standards differ significantly from the requirements and terminology of the SEC set forth in the SEC’s Industry Guide 7 (“SEC Industry Guide 7”). Accordingly, the Company’s disclosures regarding mineralization may not be comparable to similar information disclosed by companies subject to SEC Industry Guide 7. Without limiting the foregoing, while the terms “mineral resources”, “inferred mineral resources”, “indicated mineral resources” and “measured mineral resources” are recognized and required by NI 43-101 and the CIM Standards, they are not recognized by the SEC and are not permitted to be used in documents filed with the SEC by companies subject to SEC Industry Guide 7. Mineral resources which are not mineral reserves do not have demonstrated economic viability, and US investors are cautioned not to assume that all or any part of a mineral resource will ever be converted into reserves. Further, inferred resources have a great amount of uncertainty as to their existence and as to whether they can be mined legally or economically. It cannot be assumed that all or any part of the inferred resources will ever be upgraded to a higher resource category. Under Canadian rules, estimates of inferred mineral resources may not form the basis of a feasibility study or prefeasibility study, except in rare cases. The SEC normally only permits issuers to report mineralization that does not constitute SEC Industry Guide 7 compliant “reserves” as in-place tonnage and grade without reference to unit amounts. The term “contained ounces” is not permitted under the rules of SEC Industry Guide 7. In addition, the NI 43-101 and CIM Standards definition of a “reserve” differs from the definition in SEC Industry Guide 7. In SEC Industry Guide 7, a mineral reserve is defined as a part of a mineral deposit which could be economically and legally extracted or produced at the time the mineral reserve determination is made, and a “final” or “bankable” feasibility study is required to report reserves, the three-year historical price is used in any reserve or cash flow analysis of designated reserves and the primary environmental analysis or report must be filed with the appropriate governmental authority. The mine economics presented herein and derived from the PEA are preliminary in nature and may not be realized. The PEA is not a feasibility study. U.S. investors are urged to consider closely the disclosure in our latest reports and registration statements filed with the SEC. You can review and obtain copies of these filings at http://www.sec.gov/edgar.shtml. U.S. Investors are cautioned not to assume that any defined resource will ever be converted into SEC Industry Guide 7 compliant reserves.

This press release is not, and is not to be construed in any way as, an offer to buy or sell securities in the United States.

The United States Securities and Exchange Commission (“SEC”) limits disclosure for U.S. reporting purposes to mineral deposits that a company can economically and legally extract or produce.
Resource
estimates contained in
this
press release
are made pursuant to NI 43-101 standards in Canada and do not represent reserves under the standards of the SEC’s Industry Guide 7
.
Under the currently applicable SEC Industry Guide 7 standards, a “final” or “bankable” feasibility study is required to report reserves, the three-year historical average price is used in any reserve or cash flow analysis to designate reserves and all necessary permits and government approvals must be filed with the appropriate governmental authority.
This press release
uses the terms “M
easured R
esources”, “Indicated R
esou
rces”, and
“Inferred
R
esources”. We advise U.S. investors that while these terms are
Canadian mining terms as defined in accordance with NI 43-101, such terms are not recognized under SEC Industry Guide 7 and normally are not permitted to be used in reports and registration statements filed with the SEC. Mineral resources described in th
is press release
have a great amount of uncertainty as to their economic and legal feasibility. The SEC normally only permits issuers to report mineralization that does not constitute SEC Industry Guide 7 compliant “reserves” as in-place tonnage and grade, without reference to unit measures.
“Inferred R
esources” have a great amount of uncertainty as to their existence, and great uncertainty as to their economic and legal feasibility. It cannot be assumed that
any or all part of an Inferred R
esource will ever be upgraded to a higher category.

U.S. Investors are cautioned not to assume that any part or all of mineral deposits in these categories will ever be converted into SEC Industry Guide 7 reserves.

 

 Previously Announced Business Combination with Onyx Enterprises Int’l, Corp. Remains Expected to Close by November 20, 2020

New York, NY, Nov. 17, 2020 (GLOBE NEWSWIRE) — Legacy Acquisition Corp. (NYSE: “LGC”) (“Legacy”), a publicly-traded Special Purpose Acquisition Company, announced that, at Legacy’s special meeting of stockholders (the “Special Meeting”) held virtually at 10:00 am Eastern Time on November 16, 2020, its stockholders approved an amendment to Legacy’s amended and restated certificate of incorporation, as amended by that amendment to the amended and restated certificate of incorporation, dated October 22, 2019, as further amended by that second amendment to the amended and restated certificate of incorporation, dated May 18, 2020, as further amended by that third amendment to the amended and restated certificate of incorporation, dated September 4, 2020 (the “Charter Amendment”), to give Legacy the option to extend the date by which Legacy has to consummate a business combination (the “Extension”) from November 20, 2020 to December 31, 2020. At the Special Meeting, Legacy’s stockholders also approved an amendment to Legacy’s investment management trust agreement, dated as of November 16, 2017, as amended by that amendment no. 1 to investment management trust agreement, dated October 22, 2019, as further amended by that amendment no. 2 to investment management trust agreement, dated May 18, 2020, between Legacy and Continental Stock Transfer & Trust Company (the “Trust Amendment”), to give Legacy the option to extend the date on which to commence liquidating the trust account established in connection with Legacy’s initial public offering in the event Legacy has not consummated a business combination from November 20, 2020 to December 31, 2020.

As previously announced, Legacy and Onyx Enterprises Int’l, Corp., a New Jersey corporation (“Onyx”), intend to consummate the business combination (the “Business Combination”) pursuant to the Business Combination Agreement (the “Business Combination Agreement”), dated September 18, 2020, by and among Legacy, Excel Merger Sub I, Inc., Excel Merger Sub II, LLC, Onyx and Shareholder Representative Services LLC. Legacy will only implement the Extension (and effect the Charter Amendment and the Trust Amendment), if Legacy’s management does not believe that Legacy will be able to consummate the Business Combination by the current deadline of November 20, 2020.

In connection with the Extension, Legacy’s stockholders elected to redeem 37,291 shares of Legacy’s Class A common stock, par value $0.0001 per share (the “public shares”), issued in Legacy’s initial public offering. As a result, an aggregate of approximately $387,200 (or approximately $10.38 per share) will be removed from Legacy’s trust account to pay such stockholders. Following such redemptions, approximately 6,085,408 public shares will remain issued and outstanding.  

As was previously indicated in the definitive proxy statement filed with the Securities and Exchange Commission (the “SEC”) on November 4, 2020, in connection with the Extension, Legacy intends to make a cash contribution (“Contribution”) to the trust account in an amount equal to $0.03 for each public share that was not redeemed in connection with the stockholder approval of the Extension Amendment only if the Extension is effected and the Business Combination is not consummated by November 20, 2020. The Contribution (if any) will not accrue interest and the aggregate amount of the Contribution will be calculated and paid in full at the closing of the Business Combination from the proceeds of the Business Combination.

On November 4, 2020, Legacy filed a definitive consent solicitation statement with the SEC in connection with the amendments (the “Warrant Amendments”) to the Warrant Agreement, dated as of November 16, 2017, between Legacy and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agreement”). Legacy must receive consents signed by the holders of at least 65% of the outstanding public warrants in order to approve the Warrant Amendments. As of November 13, 2020, holders of 67.14% of the outstanding public warrants have consented to the Warrant Amendments.

Legacy and Onyx believe that all of the conditions to closing under the Business Combination Agreement have been met or will be met (other than those conditions which by their nature are satisfied simultaneously with closing), and Legacy anticipates that the closing of the Business Combination will occur, on or before November 20, 2020. Legacy management, therefore, believes that the closing of the Business Combination is capable of being consummated substantially contemporaneously with the expiration of the tender offer at 12:01 a.m. Eastern on November 19, 2020 (or within three business days thereafter).  

About Legacy Acquisition Corp.

Legacy raised $300 million in November 2017 and its securities are listed on the New York Stock Exchange (“NYSE”). At the time of its listing, Legacy was the only Special Purpose Acquisition Company on the NYSE led predominantly by African American managers and sponsor investors. Legacy was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more target businesses. Legacy is sponsored by a team of proven leaders primarily comprised of former Procter & Gamble executives and is supported by a founder/shareholder group of proven operationally based value builders. These executives have extensive experience in building brands and transforming businesses for accelerated growth. Legacy’s founders and management expectation is that Legacy will serve as a role model for African Americans and other under-represented business leaders to achieve success not just in the executive ranks of large Corporations, but also as entrepreneurs in the productive use of capital through mergers and acquisitions on Wall Street. For more information please visit www.LegacyAcquisition.com.

Forward-Looking Statements

This Press Release contains certain forward-looking statements. Legacy’s and Onyx’s actual results may differ from their expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “propose,” “plan,” “contemplate,” “may,” “will,” “might,” “shall,” “would,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” “positioned,” “goal,” “conditional,” “opportunities” and similar expressions are intended to identify such forward-looking statements. 

These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside Legacy’s and Onyx’s control and are difficult to predict. Factors that may cause such differences include, but are not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the Business Combination Agreement, (2) the outcome of any legal proceedings that may be instituted against Legacy and other transaction parties following the announcement of the Business Combination Agreement and the transactions contemplated therein; (3) the inability to complete the proposed Business Combination, including due to the inability to satisfy conditions to closing in the Business Combination Agreement; (4) the occurrence of any event, change or other circumstance that could otherwise cause the Business Combination to fail to close; (5) the receipt of an unsolicited offer from another party for an alternative business transaction that could interfere with the proposed Business Combination; (6) the inability to obtain or maintain the listing of the post-acquisition company’s Class A common stock on the NYSE (or such other nationally recognized stock exchange on which shares of the post-acquisition company’s Class A common stock are then listed) following the proposed Business Combination; (7) the risk that the proposed Business Combination disrupts current plans and operations as a result of the announcement and consummation of the proposed Business Combination; (8) the ability to recognize the anticipated benefits of the proposed Business Combination, which may be affected by, among other things, competition, the ability of the combined company to operate cohesively as a standalone group, grow and manage growth profitably and retain its key employees; (9) costs related to the proposed Business Combination; (10) changes in applicable laws or regulations; (11) the possibility that Onyx or the combined company may be adversely affected by other economic, business, and/or competitive factors; (12) the aggregate number of Legacy shares tendered in the tender offer by the holders of Legacy’s Class A common stock in connection with the proposed Business Combination; (13) disruptions in the economy or business operations of Onyx or its suppliers due to the impact of COVID-19; (14) the outcome of pending legal proceedings with certain Onyx stockholders; (15) potential adjustments to the unaudited non-GAAP interim financial results of Onyx; and (16) other risks and uncertainties indicated from time to time in the information statement relating to the proposed Business Combination, including those under “Risk Factors” therein, and in Legacy’s other filings with the SEC, including the Definitive Information Statement on Schedule 14C and the Schedule TO that were filed with the SEC in connection with the Business Combination. Legacy cautions that the foregoing list of factors is not exclusive. Legacy cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Legacy does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based.

No Offer or Solicitation

This Press Release shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the proposed Business Combination. This Press Release shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of section 10 of the Securities Act, or in accordance with an exemption from registration therefrom.

Legacy/Investors:

Dawn Francfort / Brendon Frey

ICR

[email protected]

Media:

Keil Decker
ICR
[email protected]